Morphine: the story on HearLore

Morphine

In December 1804, a German pharmacist named Friedrich Sertürner isolated a single substance from opium that would change the course of medicine forever. This substance, which he named morphium after the Greek god of dreams, Morpheus, was the first active alkaloid ever extracted from a plant. Sertürner's discovery was not merely a chemical curiosity; it was a revelation that a specific molecule could be separated from the complex mixture of opium to produce a potent painkiller. He tested this new substance on himself, three young boys, three dogs, and a mouse, and the results were terrifying. All four human subjects almost died, and the animals suffered severe reactions. Sertürner realized that while his discovery was powerful, it was also dangerous. He warned the world about the terrible effects of this new substance, fearing that it would cause calamity. Despite his warnings, the drug was first marketed to the general public by Sertürner and Company in 1817 as a pain medication and also as a treatment for opium and alcohol addiction. The drug was first used as a poison in 1822 when Edme Castaing of France was convicted of murdering a patient. Commercial production began in Darmstadt, Germany, in 1827 by the pharmacy that became the pharmaceutical company Merck, with morphine sales being a large part of their early growth. The invention of the hypodermic syringe in 18531855 further revolutionized its use, allowing for direct injection into the body. Sertürner himself became addicted to the drug, a tragic irony that underscored the very real dangers he had identified. His initial hypothesis that lower doses would be less addictive proved false, as morphine was found to be more addictive than either alcohol or opium. The drug's history is a testament to the double-edged nature of medical breakthroughs, where the same substance that relieves suffering can also destroy lives.

The Civil War And The Soldier's Disease

The American Civil War became the crucible in which the addictive potential of morphine was first widely recognized on a massive scale. During the conflict, morphine was used extensively to treat wounded soldiers, leading to an alleged 400,000 cases of what was termed the soldier's disease. This phrase, which first appeared in print in 1915, described the phenomenon of soldiers becoming addicted to morphine after being treated for battlefield injuries. The scale of this addiction was staggering, with many soldiers returning home unable to function without the drug. The myth of the soldier's disease has been a subject of controversy, with some suggesting that the condition was in fact a fabrication or exaggeration. However, the reality of the situation was clear: morphine was highly addictive, and its widespread use during the war had profound consequences for the lives of countless individuals. The drug was used to treat pain from myocardial infarction, kidney stones, and during labor, but its addictive nature made it a double-edged sword. The Civil War era marked a turning point in the history of morphine, as it became the most commonly abused narcotic analgesic in the world until heroin was synthesized and came into use. The drug's history is a testament to the challenges of balancing pain relief with the risk of addiction, a challenge that continues to this day. The story of the soldier's disease is a reminder of the human cost of medical innovation, and the need for careful regulation and monitoring of powerful drugs.

When did Friedrich Sertürner isolate morphine from opium?

Friedrich Sertürner isolated morphine from opium in December 1804. He named the substance morphium after the Greek god of dreams, Morpheus, and it became the first active alkaloid ever extracted from a plant.

What year did commercial production of morphine begin in Darmstadt Germany?

Commercial production of morphine began in Darmstadt, Germany, in 1827. The pharmacy that started production later became the pharmaceutical company Merck, and morphine sales were a large part of their early growth.

How many stereoisomeric forms does the morphine molecule have?

The morphine molecule exists in 32 stereoisomeric forms due to having five stereogenic centers. The desired analgesic activity resides exclusively in the natural product, the (-)-enantiomer with the configuration 5R,6S,9R,13S,14R.

When was the existence of endogenous morphine in the human body discovered?

Scientists discovered that morphine occurs naturally in the human body in 2003. This finding ended thirty years of speculation about the existence of endogenous morphine and the mu3-opioid receptor in human tissue.

Which six countries consumed 79% of the world's morphine supply in 2005?

Australia, Canada, France, Germany, the United Kingdom, and the United States consumed 79% of the world's morphine supply according to a 2005 estimate by the International Narcotics Control Board. These six countries account for the vast majority of global morphine consumption.

How long does it take for major morphine withdrawal symptoms to subside?

Major morphine withdrawal symptoms peak between 48 hours and 96 hours after the last dose and subside after about 8 to 12 days. Without intervention, most overt physical symptoms disappear within 7 to 10 days.

The Chemistry Of Pain

Morphine is a benzylisoquinoline alkaloid with two additional ring closures, and its chemical structure is a marvel of complexity. The molecule has five stereogenic centers and exists in 32 stereoisomeric forms, but the desired analgesic activity resides exclusively in the natural product, the (-)-enantiomer with the configuration (5R,6S,9R,13S,14R). This specific configuration is what allows morphine to bind to the mu-opioid receptor in the central nervous system, producing its pain-relieving effects. The drug interacts predominantly with the mu-delta-opioid receptor heteromer, and its intrinsic activity at the mu-opioid receptor is heavily dependent on the assay and tissue being tested. In some situations, it is a full agonist, while in others, it can be a partial agonist or even an antagonist. The activation of the mu-opioid receptor is associated with analgesia, sedation, euphoria, physical dependence, and respiratory depression. The drug also acts on kappa-opioid and delta-opioid receptors, with activation of the kappa-opioid receptor associated with spinal analgesia, miosis, and psychotomimetic effects. The delta-opioid receptor is thought to play a role in analgesia. The chemical structure of morphine has been used to create completely synthetic drugs such as the morphinan family, and other groups that have multiple members with morphine-like qualities. The modification of morphine and the aforementioned synthetics has also given rise to non-narcotic drugs with other uses such as emetics, stimulants, antitussives, anticholinergics, muscle relaxants, local anaesthetics, general anaesthetics, and others. More than 250 morphine derivatives have been developed since the last quarter of the 19th century, ranging from 25% the analgesic strength of codeine to several thousand times the strength of morphine. The structural formula of morphine was determined by 1925 by Robert Robinson, and at least three methods of total synthesis of morphine from starting materials such as coal tar and petroleum distillates have been patented. The first of these was announced in 1952 by Marshall D. Gates, Jr. at the University of Rochester. Despite these advances, the vast majority of morphine is still derived from the opium poppy by either the traditional method of gathering latex from the scored, unripe pods of the poppy, or processes using poppy straw.

The Withdrawal Cycle

Cessation of dosing with morphine creates the prototypical opioid withdrawal syndrome, which, unlike that of barbiturates, benzodiazepines, alcohol, or sedative-hypnotics, is not fatal by itself in otherwise healthy people. Acute morphine withdrawal proceeds through a number of stages, each with its own set of symptoms. Stage I, 6 hours to 14 hours after the last dose, includes drug craving, anxiety, irritability, perspiration, and mild to moderate dysphoria. Stage II, 14 hours to 18 hours after the last dose, features yawning, heavy perspiration, mild depression, lacrimation, crying, headaches, runny nose, dysphoria, and intensification of the above symptoms. Stage III, 16 hours to 24 hours after the last dose, includes an increase in all of the above, dilated pupils, piloerection, muscle twitches, hot flashes, cold flashes, aching bones and muscles, loss of appetite, and the beginning of intestinal cramping. Stage IV, 24 hours to 36 hours after the last dose, includes an increase in all of the above, including severe cramping, restless legs syndrome, loose stool, insomnia, elevation of blood pressure, fever, increase in frequency of breathing and tidal volume, tachycardia, restlessness, and nausea. Stage V, 36 hours to 72 hours after the last dose, includes an increase in all of the above, fetal position, vomiting, free and frequent liquid diarrhea, weight loss of 2 kg to 5 kg per 24 hours, increased white cell count, and other blood changes. Major withdrawal symptoms peak between 48 hours and 96 hours after the last dose and subside after about 8 to 12 days. The psychological dependence associated with morphine addiction is complex and protracted. Long after the physical need for morphine has passed, addicts will usually continue to think and talk about the use of morphine and feel strange or overwhelmed coping with daily activities without being under the influence of morphological. The psychological withdrawal from morphine is usually a long and painful process, with addicts experiencing severe depression, anxiety, insomnia, mood swings, forgetfulness, low self-esteem, confusion, paranoia, and other psychological problems. Without intervention, the syndrome will run its course, and most of the overt physical symptoms will disappear within 7 to 10 days, including psychological dependence. A high probability of relapse exists after morphine withdrawal when neither the physical environment nor the behavioral motivators that contributed to the abuse have been altered. Users of morphine have one of the highest relapse rates among all drug users, ranging up to 98% in the estimation of some medical experts.